XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Cash flows from operating activities:          
Net income $ (239) $ 1,931 $ 6,431 $ 9,310  
Adjustment to reconcile net income to net cash provided by (used in) operating activities:          
Depreciation and amortization 2,576 2,633 7,224 8,153  
Unrealized foreign currency loss     302 496  
Net gain on interest rate swaps       (248)  
Loss on sale of property and equipment     104 58  
Loss on divestitures, net of selling costs       70  
Debt discount amortization     311 928  
Share-based compensation expense     1,237 2,684  
Bad debt expense 100 300 625 710  
Inventory reserve expense     453 454  
Deferred income tax benefit     13 (595)  
Changes in operating assets and liabilities, net of acquisitions and divestitures:          
Accounts receivable     12,705 (6,090)  
Costs and estimated earnings in excess of billings on uncompleted contracts     (5,714) (5,196)  
Inventories     2,568 527  
Prepaid expense and other current assets     (1,713) (3,853)  
Deferred charges and other assets     (2,858) (1,628)  
Accounts payable and accrued expenses     443 (4,217)  
Billings in excess of costs and estimated earnings on uncompleted contracts     (13,504) 2,879  
Income taxes payable     21 (1,679)  
Other liabilities     467 (3,396)  
Net cash provided by (used in) operating activities     9,115 (633)  
Cash flows from investing activities:          
Acquisitions of property and equipment     (2,875) (3,746)  
Net cash paid for acquisition     (5,895)    
Proceeds from sale of property and equipment     605 509  
Net cash used in by investing activities     (8,165) (3,237)  
Cash flows from financing activities:          
Borrowings on revolving credit lines     87,000 38,300  
Repayments on revolving credit lines     (74,500) (44,447)  
Repayments of long-term debt     (4,384) (2,325)  
Deferred financing fees paid       (1,117)  
Payments on finance leases and financing liability     (333) (368)  
Proceeds from employee stock purchase plan and exercise of stock options       76  
Net cash provided by (used in) financing activities     7,783 (9,881)  
Effect of exchange rate changes on cash, cash equivalents and restricted cash     657 (448)  
Net increase (decrease) in cash, cash equivalents and restricted cash     9,390 (14,199)  
Cash, cash equivalents and restricted cash at beginning of period     36,958 44,438 $ 44,438
Cash, cash equivalents and restricted cash at end of period $ 46,348 $ 30,239 46,348 30,239 $ 36,958
Cash paid (received) during the period for:          
Interest     2,450 2,651  
Income taxes     $ (112) $ 5,234